Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/news/2025/06/12/curevac-stock-soars-on-biontech-buyout

6/12/2025 11:08 AM

Biotech stock CureVac NV (NASDAQ:CVAC) was last seen up 32.2% at $5.37, after news that BioNTech (BNTX) is acquiring the company in all-stock deal worth $1.25 billion. The merger is still awaiting r...

Analysts Turn Bullish on BioNTech Stock Amid Volatility

https://www.schaeffersresearch.com/content/news/2024/11/19/analysts-turn-bullish-on-biontech-stock-amid-volatility

11/19/2024 10:19 AM

BioNTech SE ADR (NASDAQ:BNTX) stock is up 2.8% to trade at $825.41 at last glance, after an Evercore ISI upgrade to "outperform" from "in-line." The analyst in question also hiked its price targ...

Fed Interest-Rate Decision in Full Focus Next Week

https://www.schaeffersresearch.com/content/news/2024/03/14/fed-interest-rate-decision-in-full-focus-next-week

3/14/2024 10:00 AM

The Federal Open Market Committee (FOMC) will make their latest interest-rate decision next week. While investors expect cuts this year, the central bank has hinted that they'll have to wait until spr...

Biotech Stock Hits 2-Year Low as Vaccine Sales Decline

https://www.schaeffersresearch.com/content/news/2023/08/07/biotech-stock-hits-2-year-low-as-vaccine-sales-decline

8/7/2023 11:05 AM

BioNTech SE (NASDAQ:BNTX) is sinking to two-year lows today, after plunging Covid vaccine sales weighed on the company's second-quarter results. The biotech name reported narrower-than-expected losse...

Hawkish Fed, Retail Sales Weigh on Wall Street

https://www.schaeffersresearch.com/content/news/2022/12/16/hawkish-fed-retail-sales-weigh-on-wall-street

12/16/2022 1:32 PM

Inflation data and the Federal Reserve's interest rate decision dictated much of this week's market movement. Investors were fiercely optimistic to start, though the U.S. budget deficit widened t...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity